Abstract. We evaluated the gonadotrophin response to acute naloxone administration (10 mg iv) in 4 male patients with isolated hypogonadotrophic hypogonadism (age range 18.5\p=n-\26 years) before and after pituitary
repeated infusions of GnRH, pituitary gonadotrophin responsiveness to GnRH was restored, whilst naloxone still did not affect gonadotrophin levels. Our data suggest that in male isolated hypogonadotrophic hypogonadism 1) the lack of pituitary response to naloxone is not due to pituitary hyporesponsiveness to GnRH; 2) endogenous opioids do not exert any inhibitory influence on GnRH secreting neurons and thus are not involved in the pathogenesis of this disease.
Endogenous opioids appear to be important regu¬ lators of gonadotrophin secretion through modu¬ lation of the pulsatile release of GnRH (Grossman et al. 1981; Moult et al. 1981 ). Naloxone, a potent and selective opioid antagonist, increased gonado¬ trophin levels in normal men , in normal cycling women during the late follicular and mid-luteal phase (Quigley & Yen 1980), while no effect was found in children at the onset of puberty (Fraioli et al. 1984) Samples from each subject were assayed in duplicate in a single assay. The sensitivity of the method was 1 mU/ml for FSH and 0.7 mU/ml for LH. The within-assay coefficients of variation were 5.7% for FSH and 7.5% for LH; the between-assay coefficients of variation were 6.5% for FSH and 8.7% for LH.
Plasma testosterone was measured by RIA after paper chromatography of plasma extracts (Forti et al. 1974 (Table 2) .
No significant modifications of FSH levels were observed either after naloxone or placebo admini¬ stration (Table 2 ).
In the hypogonadotrophic patients naloxone ad¬ ministration did not affect LH (Fig. 1) and FSH levels either before or after prolonged exposure to GnRH. In the same patients in basal conditions GnRH elicited a subnormal gonadotrophin re¬ sponse which was restored after repeated infusion of GnRH (Figs. 2 and 3 ). Mean (± sem) LH and FSH (mlU/ml) plasma levels in 6 male volunteers after placebo or 10 mg naloxone. Effects of naloxone administration on LH plasma levels (mean ± SEM) in 4 male patients affected by isolated hypogonadotrophic hypogonadism before ( -) and after ·-· repeated infusions of GnRH. The shaded area shows the range of the response in 6 normal controls. Fig. 2 . Effects of GnRH administration on LH plasma levels (mean ± SEM) in 4 male patients affected by isolated hypogonadotrophic hypogonadism before ( -) and after ·-· repeated infusions of GnRH. The shaded area shows the range of the response in 11 normal controls. Effects of GnRH administration on FSH plasma levels (mean ± SEM) in 4 male patients affected by isolated hypogonadotrophic hypogonadism before ( -) 
